GENE ONLINE|News &
Opinion
Blog

Bayer
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
WuXi Biologics Acquires Bayer’s Drug Manufacturing Facility in Wuppertal
2020-12-25
Bayer’s New Anti-Tumor Drug BAY 2416964 Receives Approval for Clinical Use in China
2020-12-23
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Foundation Medicine’s CGP Test FDA Approved as Companion Diagnostic for Bayer’s Tumor Agnostic Therapy
2020-10-26
Bayer Expands its Metastatic Breast Cancer Treatment
2020-09-18
AI Drug Pioneer Recursion Pharma Raises $239 Million Led by Leaps By Bayer
2020-09-12
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Weekly in Asia|Oct-2
2019-10-23
Weekly in Asia 2019|JULY-1
2019-07-19
Weekly in Asia 20190609-0615
2019-06-21
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
1 2
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top